|
1
|
Liu HY, Prentice EL and Webber MA:
Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob
Resist. 2(27)2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Luo Y, Yang Q, Zhang D and Yan W:
Mechanisms and control strategies of antibiotic resistance in
pathological biofilms. J Microbiol Biotechnol. 31:1–7.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Maldonado RF, Sá-Correia I and Valvano MA:
Lipopolysaccharide modification in Gram-negative bacteria during
chronic infection. FEMS Microbiol Rev. 40:480–493. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vuotto C, Longo F, Balice M, Donelli G and
Varaldo P: Antibiotic resistance related to biofilm formation in
Klebsiella pneumoniae. Pathogens. 3:743–758. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stahlhut SG, Struve C, Krogfelt KA and
Reisner A: Biofilm formation of Klebsiella pneumoniae on
urethral catheters requires either type 1 or type 3 fimbriae. FEMS
Immunol Med Microbiol. 65:350–359. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Surgers L, Boyd A, Girard PM, Arlet G and
Decré D: Biofilm formation by ESBL-producing strains of
Escherichia coli and Klebsiella pneumoniae. Int J Med
Microbiol. 309:13–18. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lüthje P and Brauner A: Virulence factors
of Uropathogenic E. coli and their interaction with the
Host. Adv Microb Physiol. 65:337–372. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Subashchandrabose S and Mobley HLT:
Virulence and fitness determinants of uropathogenic Escherichia
coli. Microbiol Spectr 3: 10.1128/microbiolspec.UTI-0015-2012,
2015.
|
|
9
|
de Pace F, Nakazato G, Pacheco A, Boldrin
de Paiva J, Sperandio V and Dias da Silveira W: The type VI
Secretion system plays a role in type 1 fimbria expression and
pathogenesis of an avian pathogenic Escherichia coli strain.
Infect Immun. 78:4990–4998. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rendón MA, Saldaña Z, Erdem AL,
Monteiro-Neto V, Vázquez A, Kaper JB, Puente JL and Girón JA:
Commensal and pathogenic Escherichia coli use a common pilus
adherence factor for epithelial cell colonization. Proc Natl Acad
Sci USA. 104:10637–10642. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Xu L, Li J, Wu W, Wu X and Ren J:
Klebsiella pneumoniae capsular polysaccharide: Mechanism in
regulation of synthesis, virulence, and pathogenicity. Virulence.
15(2439509)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Langstraat J, Bohse M and Clegg S: Type 3
fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the
Fimbrial adhesin (MrkD), facilitates biofilm formation.
Infect Immun. 69:5805–5812. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y and Ni M: Regulation of biofilm
formation in Klebsiella pneumoniae. Front Microbiol.
14(1238482)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yan J, Pu S, Jia X, Xu X, Yang S, Shi J,
Sun S and Zhang L: Multidrug resistance mechanisms of carbapenem
resistant Klebsiella pneumoniae strains isolated in
Chongqing, China. Ann Lab Med. 37:398–407. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu X, Sai F, Li L, Zhu C and Huang H:
Clinical characteristics and risk factors of catheter-associated
urinary tract infections caused by Klebsiella pneumoniae.
Ann Palliat Med. 9:2668–2677. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kushnareva М, Markhulia Kh М, Keshishyan E
and Semenov A: Ventilator-associated pneumonia caused by
Klebsiella pneumoniae in preterm newborn infants. Int J
Pediatric Res. 4:2469–5769. 2018.
|
|
17
|
Woo S, Marquez L, Crandall WJ, Risener CJ
and Quave CL: Recent advances in the discovery of plant-derived
antimicrobial natural products to combat antimicrobial resistant
pathogens: Insights from 2018-2022. Nat Prod Rep. 40:1271–1290.
2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lu L, Hu W, Tian Z, Yuan D, Yi G, Zhou Y,
Cheng Q, Zhu J and Li M: Developing natural products as potential
anti-biofilm agents. Chin Med. 14(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shamim A, Ali A, Iqbal Z, Mirza MA, Aqil
M, Kawish SM, Siddiqui A, Kumar V, Naseef PP, Alshadidi AAF and
Saheer Kuruniyan M: Natural medicine a promising candidate in
combating microbial biofilm. Antibiotics (Basel).
12(299)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bouyahya A, Dakka N, Et-Touys A, Abrini J
and Bakri Y: Medicinal plant products targeting quorum sensing for
combating bacterial infections. Asian Pac J Trop Med. 10:729–743.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Asfour HZ: Anti-quorum sensing natural
compounds. J Microsc Ultrastruct. 6:1–10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pathoor NN, Ganesh PS, Gopal RK, Anshad
AR, Shankar EM, Mariappan V, Busi S, Salim SA, Kathiresan N,
Kulanthaivel L, et al: Attenuation of biofilm-encoding genes and
virulence attributes in clinical isolates of Acinetobacter
baumannii by essential oil derived from Myroxylon
balsamum. Sci Rep. 16(2861)2026.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sharma A, Kumar A, Singh AK, Kumar KJ,
Narasimhan B and Kumar P: Ethnomedicinal uses, phytochemistry,
pharmacology, and toxicology of Ruellia tuberosa L.: A
review. Chem Biodivers. 21(e202400292)2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ravi P and Pandey BKS: Phytochemical
studies on Ruellia tuberosa: A review. Int J Pharm Biol Sci.
8:1190–1195. 2018.
|
|
25
|
Guha S, Talukdar D, Mandal GK, Mukherjee
R, Ghosh S, Naskar R, Saha P, Murmu N and Das G: Crude extract of
Ruellia tuberosa L. flower induces intracellular ROS,
promotes DNA damage and apoptosis in triple negative breast cancer
cells. J Ethnopharmacol. 332(118389)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Amajida H, Purwoko T and Susilowati A:
Antibacterial activity of ethanolic and n-hexane extracts of
Ruellia tuberosa leaves against Escherichia coli and
Bacillus subtilis bacteria. Biofarmasi J Natural Product
Biochem. 17:2580–2550. 2019.
|
|
27
|
Williams and Wilkins Publishers. Bergey's
Manual of Systematic Bacteriology. Baltimore, 2: 2001.
|
|
28
|
Clinical and Laboratory Standards
Institute (CLSI). Performance standards for antimicrobial
susceptibility testing. 32nd edition. CLSI supplement M100. Wayne
(PA), Clinical and Laboratory Standards Institute, 2022.
|
|
29
|
Balouiri M, Sadiki M and Ibnsouda SK:
Methods for in vitro evaluating antimicrobial activity: A review. J
Pharm Anal. 6:71–79. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
G S, Pathoor NN, Murthykumar K and Ganesh
PS: Targeting Pseudomonas aeruginosa PAO1 pathogenicity: The
role of Glycyrrhiza glabra in inhibiting virulence factors
and biofilms. Diagn Microbiol Infect Dis.
111(116674)2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Pathoor NN, Ganesh PS, Anshad AR, Gopal
RK, Ponmalar EM, Suvaithenamudhan S, Rudrapathy P and Shankar EM:
3-Hydroxybenzoic acid inhibits the virulence attributes and
disrupts biofilm production in clinical isolates of
Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis.
44:653–669. 2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Girija S, Duraipandiyan V, Kuppusamy PS,
Gajendran H and Rajagopal R: Chromatographic characterization and
GC-MS evaluation of the bioactive constituents with antimicrobial
potential from the pigmented ink of Loligo duvauceli. Int
Sch Res Notices. 2014(820745)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Surgers L, Boyd A, Girard PM, Arlet G and
Decré D: Biofilm formation by ESBL-producing strains of
Escherichia coli and Klebsiella pneumoniae. Int J Med
Microbiol. 309:13–18. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kirana P, Prashantkumar CS, Soundarya R,
Shwetha GS, Kalasad MN and Gayathri D: Tinospora
cordifolia's green synthesis approach: Comparative study on
biogenic and chemical synthesis of zinc oxide and zinc sulfide
nanoparticles. Materials Int. 6(40)2024.
|
|
35
|
Buchmann D, Schwabe M, Weiss R, Kuss AW,
Schaufler K, Schlüter R, Rödiger S, Guenther S and Schultze N:
Natural phenolic compounds as biofilm inhibitors of
Multidrug-resistant Escherichia coli- the role of similar
biological processes despite structural diversity. Front Microbiol.
14(1232039)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kim Y, Kim S, Cho KH, Lee JH and Lee J:
Antibiofilm activities of cinnamaldehyde analogs against
uropathogenic Escherichia coli and Staphylococcus
aureus. Int J Mol Sci. 23(7225)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Olszewska MA, Gędas A and Simões M: The
effects of eugenol, Trans-Cinnamaldehyde, citronellol, and
terpineol on Escherichia coli biofilm control as assessed by
Culture-dependent and -independent methods. Molecules.
25(2641)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rony Varughese RM, Pathoor NN, Ranganathan
P and Ganesh PS: Efficacy of Rhamnus frangula extract
against Acinetobacter baumannii biofilms: Histopathological
evidence from ex vivo goat models. World Acad Sci J. 7(36)2025.
|
|
39
|
Paula-Ramos L, da Rocha Santos CE, Camargo
Reis Mello D, Nishiama Theodoro L, De Oliveira FE, Back Brito GN,
Junqueira JC, Jorge AOC and de Oliveira LD: Klebsiella
pneumoniae planktonic and biofilm reduction by different plant
extracts: In vitro study. ScientificWorldJournal.
2016(3521413)2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zubair M: Antimicrobial and Anti-biofilm
activities of Coffea Arabica L. against the clinical strains
isolated from diabetic foot ulcers. Cureus.
16(e52539)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Keohane CE, Steele AD, Fetzer C,
Khowsathit J, Van Tyne D, Moynié L, Gilmore MS, Karanicolas J,
Sieber SA and Wuest WM: Promysalin elicits Species-selective
inhibition of Pseudomonas aeruginosa by targeting succinate
dehydrogenase. J Am Chem Soc. 140:1774–1782. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mahoney AR, Storek KM and Wuest WM:
Structure-based design of promysalin analogues to overcome
mechanisms of bacterial resistance. ACS Omega. 8:12558–12564.
2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rashiya N, Sangavi J, Padmini N,
Langeswaran K, Alagarsamy A, Selvakumar G and Saravanan M: In
silico and in vitro analysis of diethyl phthalate as a quorum
sensing inhibitor and its antitumor evaluation against MDA-MB-231
cell lines. Mol Divers. 30:761–771. 2026.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rashiya N, Padmini N, Ajilda AAK,
Prabakaran P, Durgadevi R, Veera Ravi A, Ghosh S, Sivakumar N and
Selvakumar G: Inhibition of biofilm formation and quorum sensing
mediated virulence in Pseudomonas aeruginosa by marine
sponge symbiont Brevibacterium casei strain Alu 1. Microb
Pathog. 150(104693)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Kim YR and Sang MK: Effects of
di-(2-ethylhexyl) phthalate on growth, metabolism, and virulence of
the plant pathogenic bacterium Acidovorax citrulli. Front
Cell Infect Microbiol. 13(1228713)2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Louis M, Tahrioui A, Verdon J, David A,
Rodrigues S, Barreau M, Manac'h M, Thiroux A, Luton B, Dupont C, et
al: Effect of phthalates and their substitutes on the physiology of
Pseudomonas aeruginosa. Microorganisms.
10(1788)2022.PubMed/NCBI View Article : Google Scholar
|
